iNtRON Biotechnology, Inc.
- Biotech or pharma, therapeutic R&D
- Biotech – food & agriculture
- Biotech or pharma, animal health
iNtRON Biotechnology is an endolysin-based novel drug developing company for the treatment of life-threatening bacterial infections. Endolysin-based pipelines are designed for the treatment of infective endocarditis, bacteremia and serious gram(-) bacterial infection including CRE, UTI, Pneumonia. The company is also a leader in bacteriophage-based technology for the development of novel agent for the ‘Immune & Immunotherapeutics'.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}